Breaking News Instant updates and real-time market news.

GRIL

Muscle Maker

/

+

11:05
06/09/22
06/09
11:05
06/09/22
11:05

Muscle Maker's Pokemoto signs franchise agreement for Philadelphia market

Pokemoto announced the signing of a new Pokemoto franchise agreement for the Philadelphia market, bringing the market count up to two locations when opened. The first location to open is company owned and is expected to open in Northeast Philadelphia in the coming weeks. Pokemoto has now signed 39 new franchise agreements and continues to focus its expansion strategy on franchising while also opening company owned locations in key markets. The Hawaiian poke bowl chain currently has eight locations in the development and construction stages along with multiple LOIs submitted for lease negotiations. The Pokemoto franchise model allows for an initial franchise fee of $25,000, per unit, when the agreement is signed while also providing 6% of net sales as an ongoing monthly royalty rate once each location is opened. The company does allow, in certain instances, for discounted fees for multi-unit or special agreements including the newly announced veterans program.

OTHER BREAKING NEWS FROM THE FLY

Initiation
Deckers Brands resumed with an Equal Weight at Wells Fargo » 06:51
06/27/22
06/27
06:51
06/27/22
06:51
DECK

Deckers Brands

$273.32 /

+11.79 (+4.51%)

Wells Fargo analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DECK Deckers Brands
$273.32 /

+11.79 (+4.51%)

DECK Deckers Brands
$273.32 /

+11.79 (+4.51%)

05/20/22 BTIG
Demand for Deckers brands UGG/HOKA 'not skipping a beat', says BTIG
05/20/22 Cowen
Deckers Brands price target raised to $407 from $358 at Cowen
05/20/22 Stifel
Deckers Brands price target raised to $338 from $315 at Stifel
05/20/22 Baird
Deckers Brands price target lowered to $375 from $525 at Baird
DECK Deckers Brands
$273.32 /

+11.79 (+4.51%)

DECK Deckers Brands
$273.32 /

+11.79 (+4.51%)

Hot Stocks
Genesco appoints Gregory Sandfort as lead independent director » 06:51
06/27/22
06/27
06:51
06/27/22
06:51
GCO

Genesco

$56.64 /

+2.46 (+4.54%)

Genesco Inc. announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GCO Genesco
$56.64 /

+2.46 (+4.54%)

GCO Genesco
$56.64 /

+2.46 (+4.54%)

03/10/22 CL King
Genesco's competitive moat more evident than ever, says CL King
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
Genesco initiated with a Buy at Seaport Global
11/30/21 Jefferies
Genesco assumed with a Hold at Jefferies
GCO Genesco
$56.64 /

+2.46 (+4.54%)

Recommendations
Bed Bath & Beyond price target lowered to $7 from $14 at Baird » 06:50
06/27/22
06/27
06:50
06/27/22
06:50
BBBY

Bed Bath & Beyond

$6.99 /

-0.145 (-2.03%)

Baird analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

06/22/22 BofA
BofA cuts Bed Bath & Beyond target to $3, says buybuy BABY sale unlikely
06/22/22 Wedbush
Bed Bath & Beyond price target lowered to $7 from $14 at Wedbush
06/22/22 UBS
Bed Bath & Beyond price target lowered to $5 from $12 at UBS
05/17/22 B. Riley
Bed Bath & Beyond price target lowered to $17 from $26 at B. Riley
BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

BBBY Bed Bath & Beyond
$6.99 /

-0.145 (-2.03%)

Hot Stocks
TCR2 Therapeutics names Eric Sullivan as CFO » 06:49
06/27/22
06/27
06:49
06/27/22
06:49
TCRR

TCR2 Therapeutics

$2.87 /

+0.06 (+2.14%)

TCR2 Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$2.87 /

+0.06 (+2.14%)

TCRR TCR2 Therapeutics
$2.87 /

+0.06 (+2.14%)

05/19/22 H.C. Wainwright
TCR2 Therapeutics price target lowered to $14 from $19 at H.C. Wainwright
05/12/22 Piper Sandler
TCR2 Therapeutics price target lowered to $15 from $23 at Piper Sandler
03/22/22 Piper Sandler
TCR2 Therapeutics price target lowered to $23 from $26 at Piper Sandler
01/19/22 Goldman Sachs
TCR2 Therapeutics assumed with Neutral from Buy at Goldman Sachs
TCRR TCR2 Therapeutics
$2.87 /

+0.06 (+2.14%)

Recommendations
Celanese price target lowered to $180 from $200 at Wells Fargo » 06:49
06/27/22
06/27
06:49
06/27/22
06:49
CE

Celanese

$127.55 /

+7.18 (+5.96%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CE Celanese
$127.55 /

+7.18 (+5.96%)

CE Celanese
$127.55 /

+7.18 (+5.96%)

06:16 Today Credit Suisse
Celanese initiated with an Underperform at Credit Suisse
06/16/22 Jefferies
Celanese downgraded to Hold from Buy at Jefferies
05/18/22 Piper Sandler
Celanese price target raised to $145 from $140 at Piper Sandler
04/13/22 Fermium Research
DuPont price target lowered to $78 from $87 at Fermium Research
CE Celanese
$127.55 /

+7.18 (+5.96%)

CE Celanese
$127.55 /

+7.18 (+5.96%)

CE Celanese
$127.55 /

+7.18 (+5.96%)

CE Celanese
$127.55 /

+7.18 (+5.96%)

Hot Stocks
BWX executes commercial agreement with Bayer for supply of Actinium-225 » 06:47
06/27/22
06/27
06:47
06/27/22
06:47
BWXT

BWX Technologies

$53.17 /

+2.635 (+5.21%)

, BAYRY

Bayer

$15.23 /

-0.15 (-0.98%)

BWX Technologies (BWXT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWXT BWX Technologies
$53.17 /

+2.635 (+5.21%)

BAYRY Bayer
$15.23 /

-0.15 (-0.98%)

BWXT BWX Technologies
$53.17 /

+2.635 (+5.21%)

03/16/22 BofA
BWX Technologies price target raised to $65 from $55 at BofA
12/14/21 Maxim
BWX Technologies price target lowered to $65 from $68 at Maxim
11/17/21 Maxim
BWX Technologies price target lowered to $68 from $77 at Maxim
11/02/21 Truist
BWX Technologies price target lowered to $70 from $77 at Truist
BAYRY Bayer
$15.23 /

-0.15 (-0.98%)

06/13/22 Redburn
FMC downgraded to Neutral on cost inflation at Redburn
05/19/22 UBS
Bayer price target raised to EUR 96 from EUR 90 at UBS
05/11/22 Barclays
Bayer price target raised to EUR 90 from EUR 85 at Barclays
05/11/22 Credit Suisse
Bayer price target raised to EUR 62 from EUR 56 at Credit Suisse
BWXT BWX Technologies
$53.17 /

+2.635 (+5.21%)

BAYRY Bayer
$15.23 /

-0.15 (-0.98%)

BAYRY Bayer
$15.23 /

-0.15 (-0.98%)

BAYRY Bayer
$15.23 /

-0.15 (-0.98%)

Recommendations
Carnival price target lowered to $13 from $21 at Wells Fargo » 06:47
06/27/22
06/27
06:47
06/27/22
06:47
CCL

Carnival

$10.87 /

+1.22 (+12.65%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

06/21/22 Deutsche Bank
Carnival price target lowered to $14 from $24 at Deutsche Bank
06/14/22 HSBC
Carnival price target lowered to $7.70 from $18.20 at HSBC
06/09/22 Susquehanna
Carnival initiated with a Neutral at Susquehanna
06/08/22 Morgan Stanley
Carnival price target lowered to $13 from $17 at Morgan Stanley
CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

CCL Carnival
$10.87 /

+1.22 (+12.65%)

Initiation
Blueprint Medicines initiated with an Underweight at Wells Fargo » 06:47
06/27/22
06/27
06:47
06/27/22
06:47
BPMC

Blueprint Medicines

$60.12 /

+3.75 (+6.65%)

Wells Fargo analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$60.12 /

+3.75 (+6.65%)

BPMC Blueprint Medicines
$60.12 /

+3.75 (+6.65%)

06/14/22 Morgan Stanley
Blueprint Medicines price target lowered to $65 from $92 at Morgan Stanley
06/09/22 Citi
Citi downgrades Blueprint to Sell on Ayvakit market concerns
06/09/22 Citi
Blueprint Medicines downgraded to Sell from Neutral at Citi
06/03/22 Wedbush
Wedbush downgrades Turning Point, says deal positive for small/mid-cap biotechs
BPMC Blueprint Medicines
$60.12 /

+3.75 (+6.65%)

BPMC Blueprint Medicines
$60.12 /

+3.75 (+6.65%)

Initiation
Eve Holding initiated with a Neutral at BTIG » 06:46
06/27/22
06/27
06:46
06/27/22
06:46
EVEX

Eve Holding

$6.31 /

+0.135 (+2.19%)

BTIG analyst Marvin Fong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVEX Eve Holding
$6.31 /

+0.135 (+2.19%)

EVEX Eve Holding
$6.31 /

+0.135 (+2.19%)

Downgrade
Cracker Barrel downgraded to Underperform from Neutral at BofA » 06:46
06/27/22
06/27
06:46
06/27/22
06:46
CBRL

Cracker Barrel

$89.74 /

+3.73 (+4.34%)

BofA analyst Sara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBRL Cracker Barrel
$89.74 /

+3.73 (+4.34%)

CBRL Cracker Barrel
$89.74 /

+3.73 (+4.34%)

06:05 Today BofA
Cracker Barrel downgraded to Underperform from Neutral at BofA
06/23/22 Truist
Cracker Barrel price target lowered to $94 from $104 at Truist
06/09/22 Deutsche Bank
Cracker Barrel price target lowered to $109 from $140 at Deutsche Bank
06/08/22 MKM Partners
Cracker Barrel price target lowered to $110 from $115 at MKM Partners
CBRL Cracker Barrel
$89.74 /

+3.73 (+4.34%)

CBRL Cracker Barrel
$89.74 /

+3.73 (+4.34%)

General news
U.S. durable goods preview » 06:45
06/27/22
06/27
06:45
06/27/22
06:45
$ECON

Economic Data

/

+

U.S. durable goods…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
U.S. pending home sales preview » 06:45
06/27/22
06/27
06:45
06/27/22
06:45
$ECON

Economic Data

/

+

U.S. pending home sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Otis Worldwide appoints Anurag Maheshwari EVP, CFO » 06:42
06/27/22
06/27
06:42
06/27/22
06:42
OTIS

Otis Worldwide

$70.83 /

+2.25 (+3.28%)

Otis Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

06/22/22 Berenberg
Otis Worldwide price target lowered to $80 from $88 at Berenberg
05/24/22 Barclays
Otis Worldwide upgraded to Overweight from Equal Weight at Barclays
04/26/22 Cowen
Otis Worldwide price target lowered to $85 from $91 at Cowen
04/26/22 Barclays
Otis Worldwide price target lowered to $80 from $88 at Barclays
OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

OTIS Otis Worldwide
$70.83 /

+2.25 (+3.28%)

Initiation
Darden reinstated with a Buy at BofA » 06:41
06/27/22
06/27
06:41
06/27/22
06:41
DRI

Darden

$119.79 /

+4.17 (+3.61%)

BofA analyst Katherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRI Darden
$119.79 /

+4.17 (+3.61%)

DRI Darden
$119.79 /

+4.17 (+3.61%)

06:38 Today BofA
Correction: Darden reinstated with a Buy at BofA
06/24/22 BMO Capital
Darden price target lowered to $130 from $140 at BMO Capital
06/24/22 RBC Capital
Darden price target lowered to $143 from $151 at RBC Capital
06/24/22 Morgan Stanley
Darden price target lowered to $148 from $161 at Morgan Stanley
DRI Darden
$119.79 /

+4.17 (+3.61%)

DRI Darden
$119.79 /

+4.17 (+3.61%)

Syndicate
Cerberus Cyber files $300M mixed securities shelf  06:40
06/27/22
06/27
06:40
06/27/22
06:40
CISO

Cerberus Cyber

$5.26 /

-0.22 (-4.01%)

 
ShowHide Related Items >><<
CISO Cerberus Cyber
$5.26 /

-0.22 (-4.01%)

  • 14
    Jan
CISO Cerberus Cyber
$5.26 /

-0.22 (-4.01%)

Recommendations
FedEx price target raised to $339 from $328 at Loop Capital » 06:39
06/27/22
06/27
06:39
06/27/22
06:39
FDX

FedEx

$243.26 /

+15.71 (+6.90%)

Loop Capital analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

06/24/22 BofA
FedEx price target raised to $276 from $265 at BofA
06/24/22 Wells Fargo
FedEx price target raised to $282 from $277 at Wells Fargo
06/24/22 UBS
FedEx price target raised to $312 from $300 at UBS
06/24/22 JPMorgan
FedEx price target raised to $284 from $279 at JPMorgan
FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

FDX FedEx
$243.26 /

+15.71 (+6.90%)

Recommendations
Reynolds Consumer Products price target lowered to $28 from $31 at Citi » 06:38
06/27/22
06/27
06:38
06/27/22
06:38
REYN

Reynolds Consumer Products

$27.37 /

+0.37 (+1.37%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs
04/13/22 Stifel
Reynolds Consumer Products downgraded to Hold from Buy at Stifel
03/30/22 JPMorgan
Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan
03/29/22 Goldman Sachs
Reynolds Consumer Products downgraded to Sell from Buy at Goldman Sachs
REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

REYN Reynolds Consumer Products
$27.37 /

+0.37 (+1.37%)

Upgrade
Vermilion Energy upgraded to Outperform from Sector Perform at Scotiabank » 06:37
06/27/22
06/27
06:37
06/27/22
06:37
VET

Vermilion Energy

$17.86 /

+0.86 (+5.06%)

Scotiabank analyst Gavin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

06/16/22 National Bank
Vermilion Energy price target lowered to C$52 from C$53 at National Bank
06/15/22 CIBC
Vermilion Energy price target raised to C$34 from C$32 at CIBC
06/08/22 Scotiabank
Vermilion Energy price target raised to C$36 from C$30 at Scotiabank
06/02/22 CIBC
Vermilion Energy price target raised to C$32 from C$25 at CIBC
VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

VET Vermilion Energy
$17.86 /

+0.86 (+5.06%)

Initiation
Enovis assumed with a Buy at Loop Capital » 06:37
06/27/22
06/27
06:37
06/27/22
06:37
ENOV

Enovis

$58.28 /

+2.84 (+5.12%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENOV Enovis
$58.28 /

+2.84 (+5.12%)

ENOV Enovis
$58.28 /

+2.84 (+5.12%)

06/16/22 Wells Fargo
Enovis initiated with an Equal Weight, $61 price target at Wells Fargo
06/16/22 Wells Fargo
Enovis initiated with an Equal Weight at Wells Fargo
05/13/22 Loop Capital
ESAB initiated with a Hold at Loop Capital
05/11/22 Baird
Enovis price target lowered to $73 from $79 at Baird
ENOV Enovis
$58.28 /

+2.84 (+5.12%)

ENOV Enovis
$58.28 /

+2.84 (+5.12%)

Recommendations
Citi cuts S&P 500 year-end target, sees positive second half setup » 06:36
06/27/22
06/27
06:36
06/27/22
06:36
SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$390.07 /

+11.955 (+3.16%)

Citi analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
02/18/22 Stifel
Stifel says S&P 500 correction in Q1 isn't over
02/17/22 JPMorgan
JPMorgan now expects seven rate hikes in this year, up from five
SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

05/19/22 Goldman Sachs
Goldman Sachs sees 35% chance of U.S. recession in next two years
03/07/22 Citi
Citi lowers year-end 2022 S&P 500 target on geopolitical risk
02/18/22 Stifel
Stifel says S&P 500 correction in Q1 isn't over
02/17/22 JPMorgan
JPMorgan now expects seven rate hikes in this year, up from five
SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

SPX S&P 500
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$390.07 /

+11.955 (+3.16%)

Hot Stocks
Cemex launches new Green Financing Framework » 06:36
06/27/22
06/27
06:36
06/27/22
06:36
CX

Cemex

$3.90 /

+0.165 (+4.42%)

CEMEX announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CX Cemex
$3.90 /

+0.165 (+4.42%)

CX Cemex
$3.90 /

+0.165 (+4.42%)

06/10/22 Berenberg
Cemex downgraded to Hold from Buy at Berenberg
04/20/22 Credit Suisse
Cemex upgraded to Outperform from Neutral at Credit Suisse
04/04/22 Goldman Sachs
Cemex downgraded to Neutral from Buy at Goldman Sachs
02/23/22 Credit Suisse
Cemex downgraded to Neutral from Outperform at Credit Suisse
Initiation
Brinker reinstated with an Underperform at BofA » 06:35
06/27/22
06/27
06:35
06/27/22
06:35
EAT

Brinker

$23.94 /

+0.345 (+1.46%)

BofA analyst Sara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

06:12 Today BofA
Brinker reinstated with an Underperform at BofA
06/16/22 Citi
Brinker price target lowered to $27 from $40 at Citi
06/09/22 Barclays
Brinker price target lowered to $34 from $38 at Barclays
06/03/22 MKM Partners
Brinker price target lowered to $40 from $45 at MKM Partners
EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

EAT Brinker
$23.94 /

+0.345 (+1.46%)

Recommendations
Warby Parker price target lowered to $15 from $18 at Loop Capital » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
WRBY

Warby Parker

$13.94 /

+0.465 (+3.45%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

05/17/22 Goldman Sachs
Warby Parker downgraded to Neutral from Buy at Goldman Sachs
05/17/22 Baird
Warby Parker price target lowered to $30 from $40 at Baird
05/17/22 Citi
Warby Parker price target lowered to $29 from $41 at Citi
03/30/22 Stifel
Warby Parker initiated with a Hold at Stifel
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

  • 29
    Sep
WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

WRBY Warby Parker
$13.94 /

+0.465 (+3.45%)

Hot Stocks
BiomX announces dosing of first two patients in Phase 1b/2a study of BX004 » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
PHGE

BiomX

/

+

BiomX announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHGE BiomX
/

+

PHGE BiomX
/

+

05/12/22 Ladenburg
BiomX price target lowered to $8 from $13 at Ladenburg
03/31/22 Chardan
BiomX price target lowered to $12 from $13 at Chardan
10/19/21 Chardan
BiomX price target lowered to $16 from $28 at Chardan
10/18/21 H.C. Wainwright
BiomX price target lowered to $10 from $20 at H.C. Wainwright
Hot Stocks
Beam Therapeutics to present new research at FASEB conference » 06:34
06/27/22
06/27
06:34
06/27/22
06:34
BEAM

Beam Therapeutics

$42.55 /

+0.985 (+2.37%)

Beam Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

06/16/22 BMO Capital
Beam Therapeutics initiated with a Market Perform at BMO Capital
04/28/22 Credit Suisse
Beam Therapeutics initiated with a Neutral at Credit Suisse
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
01/05/22 Guggenheim
Guggenheim starts Beam Therapeutics with a Buy rating, $130 price target
BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

BEAM Beam Therapeutics
$42.55 /

+0.985 (+2.37%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.